DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Hurvitz SA.
Is the duration of adjuvant trastuzumab debate still clinically relevant?.
Lancet 2019;
393 (10191) 2565-2567
We do not assume any responsibility for the contents of the web pages of other providers.